SLC30A1 and gastric cancer: Upregulated expression of SLC30A1, 5–7, and 9 predicted a favorable prognosis in GC patients with stage III/IV, I/III/IV, I/III/IV, I/III/IV, and I/III/IV, respectively (Table 3).